- Joined
- Aug 26, 2011
- Messages
- 10,528
- Reaction Score
- 12,482
JNJ: Overreaction? Reportedly, may have impacted six (6) females b/tw 18-48 years old. After 7 million JNJ SARS-2 innoculations, six (6) potentially related albeit unconfirmed clotting issues. Tragic for 1 family, yet only 1 death. Interestingly, similar clotting concerns exist with females using contraceptives. Additionally, it's unclear whether the purported JNJ clotting risk even matches general risks of other SARS-2 vaccines.
Nonetheless appropriate CDC, FDA and JNJ caution. Anecdotal, yet my wife in the age range experienced no significant issues. Almost sold some MRNA yet resisted on resulting spike, but added more JNJ to LT retirement hold. SARS-2 or not, the US and average global population's not getting younger.
Nonetheless appropriate CDC, FDA and JNJ caution. Anecdotal, yet my wife in the age range experienced no significant issues. Almost sold some MRNA yet resisted on resulting spike, but added more JNJ to LT retirement hold. SARS-2 or not, the US and average global population's not getting younger.
Last edited:
